Navigation Links
PhysAssist IQ

ProductsPhysAssist IQ
Company MedQuist Inc.
Item PhysAssist IQ
Features 
  • Allows physicians to capture dictation at the point of care or between appointments, optimizing the use of their time.
  • Provides a secure, wireless means to dictate patient information for integration into your organizations workflow system, anytime, anywhere freeing physicians of the need to be tethered to a dictation station.
  • Automatically associates the correct patient information with the dictation to help ensure accurate patient records and save redundant data entry.
  • Gives physicians the power to choose from a variety of Palm or Windows-based handheld devices for voice and data capture, allowing users to take advantage of the solution that best meets their needs.
    • Description Physicians now can have accurate patient information and secure dictation capabilities in the palm of their hands. Keep track of patient schedules, manage daily workflow and record dictation with a Palm OS or Pocket PC handheld device. PhysAssist IQ is a handheld PDA designed to be a user-intuitive product that does not require physicians to change the way they dictate.

    The PhysAssist IQ solution is easy to install, requires minimal technical support and facilitates remote management of client and handheld software. MedQuist offers flexible health information management solutions through the right blend of products, services and technologies, including Internet-hosted technology, coding services, digital dictation systems, document distribution, speech recognition, template-based products and transcription services.

    Info MedQuist Inc.
    Customer Service: (800) 233-3030
    Web site: http://www.medquist.com

    Related medicine products :

    1. TLC Self-Retaining Retractor System
    2. Assistant Free™ Self-Retaining Hip Surgery Retractor System
    3. Bika-Bicanaliculus Intubation
    4. Crawford Bicanaliculus Intubation
    5. Ritleng Bicanaliculus Intubation
    6. Lacrimal Intubation Set, 23 gauge, 3/box
    7. Lacrimal Intubation Set, 27 gauge, 3/box
    8. Lacrimal Intubation Set, Olive Tip, 27 gauge, 3/box
    9. BD Visitec Lacrimal Intubation and DCR Sets
    10. Lacrimal Intubation Set
    11. Lacrimal Intubation Tubing
    The NIAGARA Thermal Retention System (TRS) maintains the temperature of prewarmed irrigation fluid continuously as it is delivered through the Corson®, Surgiflex® WAVE™, or Surgiflex D
    ...ace the eyeglasses in the EZ Meter and press the m...isplay the measurement results on its large color ... printout makes this the ideal instrument for use ...ion to being extremely easy-to-use, the EZ-200 is ...
    Simple, Effective Laparoscopic Irrigation Pumps from the Market Leader
    The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump.
    Medicine Products:
    (Date:5/12/2008)...2 /PRNewswire-USNewswire/ -- Baptist Health South,...n Miami, has agreed to,pay the United States $7,77...Claims Act and the Stark Statute between 2003 and ...ogy group that was a source of patient,referrals t...stice,announced today. The payments were made purs...
    (Date:5/12/2008)...h., May 12 /PRNewswire-USNewswire/ -- Michael A.,S...st, was installed as,president of the 15,000 membe... 143rd annual meeting of the MSMS House of Delegat...ne State University School of Medicine, Doctor,San...ic Radiology at Henry,Ford Hospital and currently ...
    (Date:5/12/2008)... NASDAQ: CRME TSX: COM, VANCOUVER, May 12 /P...AQ: CRME / TSX: COM) today announced that it will ...2008 on the afternoon of Tuesday, May 13,2008. Ca... at 4:30pm,Eastern (1:30pm Pacific) on that day to...all, please dial 416-641-6117 or,866-299-6655. The...
    (Date:5/12/2008)...lif., May 12 /PRNewswire-FirstCall/ -- MAP,Pharmac...nancial results for,the first quarter ended March ...ed March 31, 2008 was $14.3,million compared with ...,March 31, 2008, MAP Pharmaceuticals had cash, cas...million., First Quarter Financial Results, Resea...
    Breaking Medicine News(10 mins):Health News:Florida Hospital Group Pays U.S. $7,775,000 to Settle False Claims Act Allegations 2Health News:Michael A. Sandler, MD, Installed as President of Michigan State Medical Society 2Health News:Cardiome To Release 2008 First Quarter Results 2Health News:Cardiome To Release 2008 First Quarter Results 3Health News:Cardiome To Release 2008 First Quarter Results 4Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 2Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 3Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 4Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 5
    ...mercials for ‘Head and Shoulders’ Shampoo, that cl...products, is required to be// modified. Adverts f...mpoo are the ones working up more soap than requir...ad & Shoulders, has clarified its stance, insistin...
    ...ur men whose lives took a turn for the worse after.../ TeGenero and medical research company Parexel, h.... Martin Day, who is handling the case, has felt i...d attempts to solicit information about the tests ...
    ...are to be believed, reducing calories may well ext...// which appears in this week's Journal of the Ame...uthor Dr. Eric Ravussin, from Louisiana State Univ...nce already exists to suggest that calorie restric...
    ...the risk of coronary heart attack and could in gen...ated. A 10-year study of 4,400 men and women aged ...aconess Medical Centre in Boston found a link betw...e likelihood of heart disease, reported the online...
    Other Medicine News:Health News:Cut down on food to live longer!!! 2
    (Date:5/9/2008)...Fifth International Phase III Study Shows Positive... Data -, NUTLEY, N.J., May 9 /- Roc...-year Phase III study showing that ACTEMRA(TM),(to...f structural damage to,joints in patients with rhe...ctiveness of an RA treatment. The study also demon...
    (Date:5/8/2008)...CLEVELAND, May 8 /- DATATRA...gy and services company focused on global,eClinica...y reported its,operating results for the first qua...1, 2008, revenue decreased,approximately 41% to $2...2,233,000), or $(0.16) per share on both a basic a...
    (Date:5/8/2008)...BOSTON, May 8 /- The Cancer Research ...ation,s top cancer centers, is asking,303 million ...onating $1 to,cancer research efforts this Mother,... the "Infinite Power of One(TM)" has two key goals... into their own hands by,joining together to exerc...
    (Date:5/8/2008)...cacy and safety data support potential of asenapin...ia and bipolar I disorder, WASHINGTON, May 8 /PRN...(NYSE: SGP ) today announced that an overview of ... was presented at the 161st Annual Meeting of the,...C., May 3-8. Data from,the studies, involving pati...
    Breaking Medicine Technology:New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7Cleaner Air Leads to Healthier Lungs 7677 1Cleaner Air Leads to Healthier Lungs 7677 2Cleaner Air Leads to Healthier Lungs 7677 3GNC Franchising Expected to Grow Through 2008 7673 1GNC Franchising Expected to Grow Through 2008 7673 2Ventas Grants Stock Awards to Promote Long Term Retention and Reward Performance 7669 1Ventas Grants Stock Awards to Promote Long Term Retention and Reward Performance 7669 2Ventas Grants Stock Awards to Promote Long Term Retention and Reward Performance 7669 3Ventas Grants Stock Awards to Promote Long Term Retention and Reward Performance 7669 4Medical Industry Offers Food Ingredient Companies More Than One Billion Reasons to Think Healthy 7665 1Medical Industry Offers Food Ingredient Companies More Than One Billion Reasons to Think Healthy 7665 2
    ...n 12, 2007 - Critical,Therapeutics, Inc. (Nasdaq: ... a pivotal Phase III clinical trial of ZYFLO CR(TM...2007 issue of the,Journal of Asthma. ZYFLO CR was ...(FDA) on May 30, 2007. Critical Therapeutics,toge..., expects to,begin marketing ZYFLO CR in the U.S. ...
    ... Efficacy with Either Every,Two Weeksn or Monthly ...CET - New pivotal data,(RAPID 1 and RAPID 2) prese...gy (EULAR) show that Cimzia (certolizumab pegol), ...th methotrexate,therapy has a rapid and significan...ive rheumatoid arthritis (RA) compared with,methot...
    Other Medicine Technology:Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 2Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 3Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 4Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 5Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 2Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 3Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 4Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 5Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 6Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 7Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 8